DaVita Responds to Proposition 23 in California

Rhea-AI Summary

DaVita Kidney Care has expressed gratitude following the defeat of Proposition 23 in California, which could have threatened access to dialysis for over 80,000 patients. The company criticized the SEIU-UHW labor union for its opposition to the dialysis community and reaffirmed its commitment to prioritizing patient health and safety. DaVita is a leading provider of kidney care services in the U.S., serving 205,300 patients at 2,809 centers nationwide as of September 30, 2020, and has been a pioneer in clinical quality and innovation in kidney care.

Positive

• DaVita's opposition to Proposition 23 aligns with preserving access to dialysis care for over 80,000 patients.
• The company reinforced its position as a leader in kidney care services with a commitment to patient-centered care.
• DaVita's service network includes 2,809 outpatient dialysis centers in the U.S., catering to a vast patient base.

Negative

• None.

SACRAMENTO, Calif., Nov. 4, 2020 /PRNewswire/ -- DaVita Kidney Care, a leading provider of kidney care services in the United States, issued the following statement:

"We are grateful that Californians voted down Proposition 23, a harmful ballot measure that could have jeopardized access to life-sustaining dialysis care for more than 80,000 patients. It's incredibly frustrating that despite not understanding dialysis or our patients, the labor union, SEIU-UHW, continues its attempt to harm patients in the dialysis community. We remain focused on putting our patients' health and safety first and will continue to oppose misguided policy attacks."

About DaVita Kidney Care
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. Through DaVita Kidney Care, the company treats patients with chronic kidney failure and end stage kidney disease. DaVita is committed to bold, patient-centric care models, implementing the latest technologies and moving toward integrated care offerings for all. Through these efforts, DaVita has also become the largest provider of home dialysis in the country. As of September 30, 2020, DaVita served 205,300 patients at 2,809 outpatient dialysis centers in the United States. The company also operated 291 outpatient dialysis centers in nine countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.

Contact Information
Media:
Alicia Patterson
Alicia.Patterson@davita.com
303-876-6982

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/davita-responds-to-proposition-23-in-california-301166204.html

SOURCE DaVita

FAQ

What is DaVita's stance on Proposition 23?

DaVita opposed Proposition 23, stating it could jeopardize dialysis care for over 80,000 patients.

How many patients does DaVita serve?

As of September 30, 2020, DaVita serves 205,300 patients across 2,809 outpatient dialysis centers in the United States.

What is the impact of Proposition 23 on dialysis care?

The defeat of Proposition 23 means continued access to life-sustaining dialysis care for patients in California.

How does DaVita contribute to kidney care?

DaVita has been a leader in clinical quality and innovation for over 20 years, focusing on patient-centric care models.

Where can I find more information about DaVita?

More information about DaVita can be found on their official website at DaVita.com/About.